Frederique Ph.D. Menzaghi Insider Trading $CARA Cara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Frederique Ph.D. Menzaghi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Frederique Ph.D. Menzaghi. Frederique Ph.D. Menzaghi is Chief Scientific Off,SVP-R&D in Cara Therapeutics, Inc. ($CARA) and Sr VP-Research & Development in Cara Therapeutics, Inc. ($CARA) and VP-Research & Development in Cara Therapeutics, Inc. ($CARA).
Frederique Ph.D. Menzaghi in Cara Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Frederique Ph.D. Menzaghi: Chief Scientific Off,SVP-R&D, Sr VP-Research & Development, VP-Research & Development
Holdings: 135,319 shares
Current Value: $2,205,700
Latest Transaction: Apr 01 2021
$CARA Market Capitalization: $449.33M
$CARA Previous Close: $16.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Frederique Ph.D. Menzaghi in Cara Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Option Exercise | A | 20.59 | 32,000 | 658,880 | 32,000 | |
| Apr 01 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 16,000 | 0 | 135,319 | 119.3 K to 135.3 K (+13.41 %) |
| Mar 08 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 17.98 | 3,358 | 60,377 | 119,319 | 122.7 K to 119.3 K (-2.74 %) |
| Mar 08 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 122,677 | 112.7 K to 122.7 K (+8.87 %) |
| Feb 25 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 19.33 | 5,003 | 96,708 | 112,677 | 117.7 K to 112.7 K (-4.25 %) |
| Feb 25 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 8,000 | 0 | 117,680 | 109.7 K to 117.7 K (+7.29 %) |
| Dec 30 2020 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 15.30 | 2,812 | 43,024 | 109,680 | 112.5 K to 109.7 K (-2.50 %) |
| Dec 29 2020 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 8,000 | 0 | 112,492 | 104.5 K to 112.5 K (+7.66 %) |
| Apr 21 2020 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 15.58 | 12,894 | 200,889 | 104,492 | 117.4 K to 104.5 K (-10.98 %) |
| Apr 21 2020 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 37,500 | 0 | 117,386 | 79.9 K to 117.4 K (+46.94 %) |
| Feb 26 2020 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Option Exercise | A | 16.36 | 32,000 | 523,520 | 32,000 | |
| Feb 26 2020 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 16,000 | 0 | 79,886 | 63.9 K to 79.9 K (+25.04 %) |
| Oct 29 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 19.91 | 4,000 | 79,640 | 63,886 | 67.9 K to 63.9 K (-5.89 %) |
| Oct 22 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 19.33 | 4,000 | 77,320 | 67,886 | 71.9 K to 67.9 K (-5.56 %) |
| Oct 16 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 18.70 | 4,000 | 74,800 | 71,886 | 75.9 K to 71.9 K (-5.27 %) |
| Oct 08 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 19.19 | 4,000 | 76,760 | 75,886 | 79.9 K to 75.9 K (-5.01 %) |
| Sep 05 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 22.92 | 20,000 | 458,400 | 79,886 | 99.9 K to 79.9 K (-20.02 %) |
| Aug 05 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 23.24 | 20,000 | 464,800 | 99,886 | 119.9 K to 99.9 K (-16.68 %) |
| Jul 19 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 27.50 | 8,996 | 247,390 | 119,886 | 128.9 K to 119.9 K (-6.98 %) |
| Jul 03 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 21.90 | 20,000 | 438,000 | 128,882 | 148.9 K to 128.9 K (-13.43 %) |
| May 30 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 21.19 | 11,397 | 241,502 | 148,882 | 160.3 K to 148.9 K (-7.11 %) |
| May 30 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 37,500 | 0 | 160,279 | 122.8 K to 160.3 K (+30.54 %) |
| Mar 14 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 18.87 | 16,803 | 317,073 | 122,779 | 139.6 K to 122.8 K (-12.04 %) |
| Mar 14 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Sell | S | 17.50 | 3,197 | 55,948 | 139,582 | 142.8 K to 139.6 K (-2.24 %) |
| Mar 08 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Option Exercise | A | 16.10 | 150,000 | 2,415,000 | 150,000 | |
| Mar 04 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 17.50 | 1,500 | 26,250 | 142,779 | 144.3 K to 142.8 K (-1.04 %) |
| Feb 27 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 17.50 | 2,200 | 38,500 | 144,279 | 146.5 K to 144.3 K (-1.50 %) |
| Jan 02 2019 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 12.53 | 4,300 | 53,879 | 146,479 | 150.8 K to 146.5 K (-2.85 %) |
| Dec 31 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Grant | A | 0.00 | 11,779 | 0 | 150,779 | 139 K to 150.8 K (+8.47 %) |
| Dec 06 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 18.36 | 3,000 | 55,080 | 139,000 | 142 K to 139 K (-2.11 %) |
| Nov 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Option Exercise | M | 2.05 | 40,000 | 82,000 | 0 | |
| Nov 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 18.77 | 3,000 | 56,310 | 142,000 | 145 K to 142 K (-2.07 %) |
| Nov 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Buy | M | 2.05 | 40,000 | 82,000 | 145,000 | 105 K to 145 K (+38.10 %) |
| Nov 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Option Exercise | M | 2.25 | 10,000 | 22,500 | 0 | |
| Nov 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Buy | M | 2.25 | 10,000 | 22,500 | 114,000 | 104 K to 114 K (+9.62 %) |
| Oct 03 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 23.99 | 3,000 | 71,970 | 95,000 | 98 K to 95 K (-3.06 %) |
| Sep 06 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 19.81 | 3,000 | 59,430 | 98,000 | 101 K to 98 K (-2.97 %) |
| Aug 22 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 18.89 | 3,000 | 56,670 | 101,000 | 104 K to 101 K (-2.88 %) |
| Jul 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 19.00 | 3,000 | 57,000 | 104,000 | 107 K to 104 K (-2.80 %) |
| Jun 05 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 15.49 | 3,000 | 46,470 | 107,000 | 110 K to 107 K (-2.73 %) |
| May 25 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 15.19 | 9,000 | 136,710 | 110,000 | 119 K to 110 K (-7.56 %) |
| Mar 13 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Option Exercise | A | 14.39 | 57,750 | 831,023 | 57,750 | |
| Feb 20 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 15.02 | 3,000 | 45,060 | 119,000 | 122 K to 119 K (-2.46 %) |
| Jan 26 2018 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Sell | S | 15.00 | 15,000 | 225,000 | 122,000 | 137 K to 122 K (-10.95 %) |
| Nov 09 2017 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Option Exercise | M | 2.48 | 20,000 | 49,600 | 0 | |
| Nov 09 2017 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Sr VP-Research & De ... | Buy | M | 2.48 | 20,000 | 49,600 | 137,000 | 117 K to 137 K (+17.09 %) |
| Aug 10 2017 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 15.00 | 3,000 | 45,000 | 117,000 | 120 K to 117 K (-2.50 %) |
| Jul 18 2017 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 15.00 | 3,000 | 45,000 | 120,000 | 123 K to 120 K (-2.44 %) |
| Mar 10 2017 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Option Exercise | A | 17.41 | 75,000 | 1,305,750 | 75,000 | |
| Apr 01 2016 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Option Exercise | A | 6.00 | 65,000 | 390,000 | 65,000 | |
| Feb 03 2016 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 9.00 | 1,000 | 9,000 | 129,000 | 130 K to 129 K (-0.77 %) |
| Feb 03 2016 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 9.05 | 5,000 | 45,250 | 130,000 | 135 K to 130 K (-3.70 %) |
| Apr 20 2016 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 9.00 | 6,000 | 54,000 | 123,000 | 129 K to 123 K (-4.65 %) |
| Jan 05 2016 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 16.80 | 6,000 | 100,800 | 135,000 | 141 K to 135 K (-4.26 %) |
| Dec 03 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 16.21 | 6,000 | 97,260 | 141,000 | 147 K to 141 K (-4.08 %) |
| Nov 03 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 14.26 | 6,000 | 85,560 | 147,000 | 153 K to 147 K (-3.92 %) |
| Oct 05 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 14.44 | 1,500 | 21,660 | 153,000 | 154.5 K to 153 K (-0.97 %) |
| Oct 05 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 13.79 | 4,500 | 62,055 | 154,500 | 159 K to 154.5 K (-2.83 %) |
| Sep 03 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 18.63 | 7,000 | 130,410 | 159,000 | 166 K to 159 K (-4.22 %) |
| Aug 05 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 21.41 | 7,000 | 149,870 | 166,000 | 173 K to 166 K (-4.05 %) |
| Jul 06 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Sell | S | 12.22 | 7,000 | 85,540 | 173,000 | 180 K to 173 K (-3.89 %) |
| Jun 17 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Option Exercise | A | 10.82 | 60,000 | 649,200 | 60,000 | |
| Mar 11 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Option Exercise | M | 0.25 | 20,000 | 5,000 | 0 | |
| Mar 11 2015 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Buy | M | 0.25 | 20,000 | 5,000 | 180,000 | 160 K to 180 K (+12.50 %) |
| Jan 31 2014 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | VP-Research & Devel ... | Option Exercise | A | 11.00 | 40,000 | 440,000 | 40,000 |
Page: 1